CELFULL to Showcase Breakthrough Anti-Aging Technologies at SupplySide Global 2025

September 29, 2025 - Coral Springs, FL - As global health consumption evolves from "basic protection" to "science-driven precision intervention," breakthroughs in anti-aging are becoming the core engine of industry growth. On October 29-30, SupplySide Global 2025, recognized as the world's leading trade show for health and nutrition innovation, will take place in Las Vegas.

Image: https://www.globalnewslines.com/uploads/2025/09/f4a7947fa594d2494a7ef6be79d5a971.jpg

At this year's event, CELFULL, a research-driven anti-aging brand, will present its latest scientific achievements, including its patented Celfavor Registered Microsphere Sustained-Release Technology, full life-cycle anti-aging solutions, and an AI-powered R&D system. These innovations are expected to be among the highlights of the show, which serves as a premier platform for global exchange, scientific advancement, and industry collaboration.

25 Years of Research: Breaking Through Global Technical Barriers

As a pioneer in serious anti-aging research and drug innovation, CELFULL has accumulated more than 25 years of expertise. The spotlight of this exhibition will be its patented Celfavor Registered Microsphere Sustained-Release Technology (U.S. Patent No. US11744804B2), an advanced formulation process that combines biotechnology with microencapsulation engineering.

Image: https://www.globalnewslines.com/uploads/2025/09/ee9aec08c920fee085910306de9ecab6.jpg

This technology employs a "multi-core + soluble wall material" structure to completely isolate active ingredients from environmental factors such as oxygen, moisture, and light. During absorption, its acid-resistant, intestine-targeted release properties solve the traditional challenges of ingredient degradation and poor bioavailability.

For example, NADH, a key anti-aging compound, typically loses 50% of its activity within 6-12 months at room temperature. When encapsulated using Celfavor Registered technology, NADH remains stable for up to 36 months under standard storage conditions-improving stability more than sixfold and enabling multi-ingredient compatibility that was previously difficult to achieve.

Image: https://www.globalnewslines.com/uploads/2025/09/3d3878bf0057b3c28e1bbf7c8ea8b8ca.jpg

CELFULL has also established a broad technical framework adaptable to vitamins, coenzymes, peptides, and more. Supported by AI-based predictive modeling, the system rapidly identifies optimal microsphere solutions for different materials, providing standardized support for functional foods, dietary supplements, and novel drug development.

Full Life-Cycle Anti-Aging Solutions

Recognizing the diverse health and longevity needs across different life stages, CELFULL will introduce comprehensive solutions covering general anti-aging, targeted interventions, and beauty-oriented care. These include strategies for systemic vitality, cardiovascular health, and ovarian rejuvenation-addressing wellness from youth to senior years, and from basic health to precision interventions.

"Our philosophy is built on the dual pillars of scientific validation and premium quality," said a CELFULL product spokesperson. "Every formulation undergoes rigorous lab testing and performance tracking to ensure results you can trust."

AI-Driven R&D: Accelerating Innovation

CELFULL is also pioneering the integration of artificial intelligence into anti-aging biology. Its AI-driven R&D framework-spanning network pharmacology, systems biology, and computer-aided drug design-greatly enhances research efficiency and accuracy.

For example, in ingredient screening, AI can analyze interactions between tens of thousands of natural compounds and aging-related targets, reducing candidate selection cycles from 6-12 months to just 1-2 months. During formulation optimization, AI simulations of metabolic pathways help predict safety and efficacy in advance, minimizing downstream risks.

Image: https://www.globalnewslines.com/uploads/2025/09/0ded531ca9cfa59be4c5e7cf272f1a69.jpg

"AI is not only a research tool but a catalyst for transforming the anti-aging industry from experience-driven to data-driven innovation," said CELFULL's R&D Director. Current AI-assisted projects have already advanced several candidate drugs-including NF-602, SM-202, NC-612, and SC-108-through critical preclinical stages.

Join CELFULL at SupplySide Global 2025

CELFULL invites attendees to explore its innovations at Booth #620 at SupplySide Global 2025, Las Vegas, October 29-30. The booth will feature a Technology Experience Zone, Product Showcase, and Consultation Area, offering live demonstrations of microsphere technology and customized anti-aging solutions.

With participation from suppliers, manufacturers, and research institutions from over 100 countries, SupplySide Global remains the most influential platform for the health and nutrition industry. CELFULL looks forward to engaging with global partners, sharing cutting-edge science, and shaping the future of healthy longevity.
Media Contact
Company Name: CELFULL BIO-TECH (USA) INC.
Contact Person: Maggie
Email: Send Email [http://www.universalpressrelease.com/?pr=celfull-to-showcase-breakthrough-antiaging-technologies-at-supplyside-global-2025]
Country: United States
Website: http://www.celfull.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. GetNews makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.